Ping Zhan1, Qing-Qing Zhu1, Ying-Ying Miu1, Ya-Fang Liu1, Xiao-Xia Wang1, Ze-Jun Zhou1, Jia-Jia Jin1, Qian Li1, Shinji Sasada2, Takehiro Izumo3, Chih-Yen Tu4, Wen-Chien Cheng4, Matthew Evison5, Tang-Feng Lv1, Yong Song1. 1. Department of Respiratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China. 2. Department of Respiratory Medicine, Tokyo Saiseikai Central Hospital, Minato-ku, Tokyo 108-0073, Japan. 3. Department of Respiratory Medicine, Japanese Red Cross Medical Center, Shibuya-ku, Tokyo 150-8935, Japan. 4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, China. 5. North West Lung Centre, University Hospital of South Manchester, Wythenshawe M23 9LT, UK.
Abstract
BACKGROUND: With the release of the National Lung Screening Trial results, the detection of peripheral pulmonary lesions (PPLs) is likely to increase. Computed tomography (CT)-guided percutaneous transthoracic needle biopsy (PTNB) and radial probe endobronchial ultrasound (r-EBUS)-guided transbronchial lung biopsy (TBLB) are recommended for tissue diagnosis of PPLs. METHODS: A systematic review of published literature evaluating the accuracy of r-EBUS-TBLB and CT-PTNB for the diagnosis of PPLs was performed to determine point sensitivity and specificity, and to construct a summary receiver-operating characteristic curve. RESULTS: This review included 31 publications dealing with EBUS-TBLB and 14 publications dealing with CT-PTNB for the diagnosis of PPLs. EBUS-TBLB had point sensitivity of 0.69 (95% CI: 0.67-0.71) for the diagnosis of peripheral lung cancer (PLC), which was lower than the sensitivity of CT-PTNB (0.94, 95% CI: 0.94-0.95). However, the complication rates observed with EBUS-TBLB were lower than those reported for CT-PTNB. CONCLUSIONS: This meta-analysis showed that EBUS-TBLB is a safe and relatively accurate tool in the investigation of PLC. Although the yield remains lower than that of CT-PTNB, the procedural risks are lower.
BACKGROUND: With the release of the National Lung Screening Trial results, the detection of peripheral pulmonary lesions (PPLs) is likely to increase. Computed tomography (CT)-guided percutaneous transthoracic needle biopsy (PTNB) and radial probe endobronchial ultrasound (r-EBUS)-guided transbronchial lung biopsy (TBLB) are recommended for tissue diagnosis of PPLs. METHODS: A systematic review of published literature evaluating the accuracy of r-EBUS-TBLB and CT-PTNB for the diagnosis of PPLs was performed to determine point sensitivity and specificity, and to construct a summary receiver-operating characteristic curve. RESULTS: This review included 31 publications dealing with EBUS-TBLB and 14 publications dealing with CT-PTNB for the diagnosis of PPLs. EBUS-TBLB had point sensitivity of 0.69 (95% CI: 0.67-0.71) for the diagnosis of peripheral lung cancer (PLC), which was lower than the sensitivity of CT-PTNB (0.94, 95% CI: 0.94-0.95). However, the complication rates observed with EBUS-TBLB were lower than those reported for CT-PTNB. CONCLUSIONS: This meta-analysis showed that EBUS-TBLB is a safe and relatively accurate tool in the investigation of PLC. Although the yield remains lower than that of CT-PTNB, the procedural risks are lower.
Authors: Gregorino Paone; Emanuele Nicastri; Gabriele Lucantoni; Raffaele Dello Iacono; Paolo Battistoni; Anna Lisa D'Angeli; Giovanni Galluccio Journal: Chest Date: 2005-11 Impact factor: 9.410
Authors: Yuqing Wei; Kaikai Shen; Tangfeng Lv; Hongbing Liu; Zimu Wang; Juan Wu; He Zhang; Sara Colella; Fu-Zong Wu; Michael T Milano; Ping Zhan; Yong Song; Zhiwei Lu Journal: Transl Lung Cancer Res Date: 2020-06
Authors: Sojung Park; Hee-Young Yoon; Yeji Han; Kyung Sook Wang; So Young Park; Yon Ju Ryu; Jin Hwa Lee; Jung Hyun Chang Journal: Thorac Cancer Date: 2020-04-27 Impact factor: 3.500